Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 03 - 15 symbols : Sny save search
Bullous Pemphigoid Market is Expected to Grow With a CAGR of 16.27% for the Study Period of 2018-2030, says DelveInsight
Published: 2021-03-15 (Crawled : 17:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
Sanofi and Regeneron Halt Cervical Cancer Trial Early Due to Dazzling Results...
Published: 2021-03-15 (Crawled : 16:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
results cancer trial
Global Meningococcal Vaccines Disease Coverage Forecast and Market Analysis to 2024: Assessment, Future Trends, Unmet Needs, Marketed Vaccines
Published: 2021-03-15 (Crawled : 15:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
disease vaccine
Sanofi and Regeneron Halt Cervical Cancer Trial Early Due to Dazzling Results, Plan to Submit to ...
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
results cancer trial
Clinical Catch-Up: March 8-12
Published: 2021-03-15 (Crawled : 13:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
Aiforia appoints Swedbank as lead advisor to explore financing options
Published: 2021-03-15 (Crawled : 09:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
Phase 3 trial of Libtayo® (cemiplimab) monotherapy in advanced cervical cancer stopped early for positive result on overall survival
Published: 2021-03-15 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.33%
H: 2.47%
C: 2.31%
positive therapy cancer phase 3 trial
Danone: New governance at Danone; Emmanuel Faber steps down as Chairman and CEO Gilles Schnepp appointed non-executive Chairman
Published: 2021-03-15 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
ceo
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.